What It Is

Retatrutide + Tirzepatide is a novel multi-receptor metabolic research blend. Tirzepatide functions as a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, while Retatrutide acts as a triple agonist targeting GIP, GLP-1, and glucagon receptors. Together, they represent the peak of multi-pathway incretin mimetic research.

What It Is Commonly Used For

• Multi-Receptor Incretin Activation: Studied for simultaneous stimulation of GLP-1, GIP, and glucagon receptor signaling pathways to examine systemic glucose and lipid homeostasis.

• Appetite & Satiety Signaling: Evaluated in metabolic models for delayed gastric emptying, suppressed central appetite signaling, and accelerated weight loss dynamics.

• Energy Expenditure & Fat Oxidation: Researched for glucagon receptor-mediated increases in basal metabolic rate and hepatic fat clearance alongside GIP/GLP-1 glycemic control.

General Purpose

To provide a combined multi-agonist incretin blend for investigating complex metabolic signaling, receptor binding affinity, glucose regulation, and profound fat oxidation in laboratory settings.

Specifications